Verrica Pharmaceuticals Inc.

NASDAQ:VRCA

5.06 (USD) • At close September 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Revenue 12.7023.4390.344-1.7815.1773.8261.9882.9170.1820.0370.0688.3190.2140.431-1200120000000000000000
Cost of Revenue 0.340.4230.6250.4350.5421.1380.3810.1450.1360.0680.0622.9460.1630.1580.20.1110.09400000000000000000
Gross Profit 12.3623.016-0.281-2.2164.6352.6881.6082.7720.046-0.0310.0065.3730.0510.273-12.2-0.111-0.094120000000000000000
Gross Profit Ratio 0.9730.877-0.8171.2440.8950.7030.8090.950.253-0.8380.0880.6460.2380.6331.0170010000000000000000
Reseach & Development Expenses 1.8462.2841.1672.4053.3194.9485.326.515.7252.7393.032.9464.1622.7233.3573.7633.4475.3622.2724.9883.5214.8923.9723.0493.9284.4874.9173.4843.6090.9291.1181.120.9770.515
General & Administrative Expenses 08.5486.18314.98315.42214.83916.99220.0545.9374.3193.1893.9255.1735.1185.1138.0057.2846.5789.7614.6495.114.9884.0183.4943.5933.5393.2713.6812.5030.9860.3160.2380.1180.055
Selling & Marketing Expenses 00.33.6961.11.11.50.004000000000000000000000000000
SG&A 8.8528.8489.87816.08316.52216.33916.99520.0545.9374.3193.1893.9255.1735.1185.1138.0057.2846.5789.7614.6495.114.9884.0183.4943.5933.5393.2713.6812.5030.9860.3160.2380.1180.055
Other Expenses 0.1540.0140.084000-0.1090.12500-0.0060.005-0.00100000-0.00100000-0.00300-0.001000000
Operating Expenses 10.85211.14611.12918.48819.84121.28722.20726.68911.6627.0586.2196.8719.3357.8418.4711.76810.73111.9412.0339.6378.6319.887.996.5437.5218.0268.1887.1656.1121.9151.4341.3581.0950.57
Operating Income 1.51-8.13-11.41-20.704-15.206-18.599-20.599-23.917-11.616-7.089-6.2131.448-9.121-7.41-8.47-11.768-10.7310.06-12.033-9.637-8.631-9.88-7.99-6.543-7.521-8.026-8.188-7.165-6.112-1.915-1.434-1.358-1.095-0.57
Operating Income Ratio 0.119-2.364-33.16911.625-2.937-4.861-10.362-8.199-63.824-191.595-91.3680.174-42.621-17.1930.706000.0050000000000000000
Total Other Income Expenses Net 0-1.612-4.792-2.156-1.98-1.732-1.478-0.8850.6260.50.281-1.365-1.047-1.06-1.07-1.061-1.044-0.996-0.944-0.849-0.7780.0580.3530.4530.520.5470.610.4260.1530.014-0.001-0.00100
Income Before Tax 0.204-9.742-16.202-22.86-17.186-20.331-24.614-24.802-10.99-6.589-5.9320.083-10.168-8.47-9.54-12.829-11.775-0.936-12.977-10.486-9.409-9.822-7.637-6.09-7.001-7.479-7.578-6.739-5.959-1.874-1.435-1.359-1.095-0.57
Income Before Tax Ratio 0.016-2.833-47.09912.835-3.32-5.314-12.381-8.503-60.385-178.081-87.2350.01-47.514-19.6520.79500-0.0780000000000000000
Income Tax Expense 0000000000-0.28101.0471.0600.0310.033000.0640000000-0.001-0.003-1.8880000
Net Income 0.204-9.742-16.202-22.86-17.186-20.331-24.614-24.802-10.99-6.589-5.6510.083-11.215-9.53-9.54-12.829-11.775-0.936-12.977-10.486-9.409-9.822-7.637-6.09-7.001-7.479-7.578-6.739-5.959-1.874-1.435-1.359-1.095-0.57
Net Income Ratio 0.016-2.833-47.09912.835-3.32-5.314-12.381-8.503-60.385-178.081-83.1030.01-52.407-22.1110.79500-0.0780000000000000000
EPS 0.022-1.03-2.41-4.88-3.7-4.37-5.31-5.38-2.394-1.532-1.4440.021-3.695-3.078-3.467-4.662-4.28-0.366-5.178-4.196-3.769-3.934-3.064-2.447-2.814-3.009-3.05-2.377-9.245-6.479-0.719-0.529-0.426-0.222
EPS Diluted 0.022-1.03-2.41-4.88-3.7-4.37-5.31-5.38-2.394-1.532-1.4440.019-3.695-3.078-3.467-4.662-4.28-0.366-5.178-4.196-3.769-3.934-3.064-2.447-2.814-3.009-3.05-2.377-9.245-6.479-0.719-0.529-0.426-0.222
EBITDA 2.534-8.13-13.6-20.142-14.484-17.672-22.092-22.935-10.783-6.387-5.7310.36-8.939-7.23-8.243-11.626-10.6040.159-11.986-9.544-8.448-9.522-7.964-6.007-6.96-7.439-6.691-6.327-5.95900-1.358-1.095-0.57
EBITDA Ratio 0.199-2.364-39.53511.309-2.798-4.619-11.113-7.863-59.247-172.622-84.2790.043-41.771-16.7750.687000.0130000000000000000